Metraipolis › archive › dc_343eb116bf28
Lights and shades of front-line treatment with covalent BTK inhibitors combined with venetoclax in patients with chronic lymphocytic leukemia — Europe PMC PMID:41488721
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41488721
- DOI
- 10.3389/or.2025.1703228
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T13:11:14.583Z
- SHA-256 of the archived text
74b3443938c186c6c22e608c9545f4bff9bb9b1f49257ea2fc5f35caf4ce894a- Stable URL of this page
https://metraipolis.com/documento/dc_343eb116bf28
How to cite
Lights and shades of front-line treatment with covalent BTK inhibitors combined with venetoclax in patients with chronic lymphocytic leukemia — Europe PMC PMID:41488721 — Europe PMC (en), https://europepmc.org/article/MED/41488721 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_343eb116bf28 (Metraipolis archive dc_343eb116bf28, sha256 74b3443938c186c6c22e608c9545f4bff9bb9b1f49257ea2fc5f35caf4ce894a)
BibTeX
@misc{dc343eb116bf28,
title = {Lights and shades of front-line treatment with covalent BTK inhibitors combined with venetoclax in patients with chronic lymphocytic leukemia — Europe PMC PMID:41488721},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41488721},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_343eb116bf28; sha256 74b3443938c186c6c22e608c9545f4bff9bb9b1f49257ea2fc5f35caf4ce894a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488721. Agents can read the archived copy with the MCP tool read_document.